Tanner Caverly has been a general internist and Health Services Research Fellow at the Ann Arbor VA Medical Center and a Clinical Lecturer at the University of Michigan Medical School since July 2013. He graduated from medical school at The Ohio State University School of Medicine and Public Health, and subsequently traveled to the University of Colorado, where he completed internal medicine residency training, a year as Chief Medical Resident, and a Primary Care Research Fellowship / Masters in Public Health.
Page not found
Carl Schneider, JD -- “Can Informed-Consent Laws Work? Evaluating Compelled Disclosure as a Method of Regulation”
Abstract: The law of informed consent is an example of a form of legal regulation called mandated disclosure. In such regulation, one party to a transaction is required to give the other party to the transaction information to use in making decisions about the parties’ relationship. There are hundreds of examples of such legal rules besides medical informed consent. This talk asks how well these rules have worked outside medicine. It concludes that there is little evidence that those rules ever work, explores some of the reasons for this surprising failure, and asks what the failure of mandated disclosure outside medicine tells us about the success of informed-consent laws in medicine.
Funded by the National Institute on Aging
Although the US spends far more on health care than other high-income countries, older Americans are sicker and have shorter lives than older adults in many other high-income countries, even after controlling for individual-level factors such as education and behavioral risks. Reasons for the US health disadvantage are not well understood. However, local amenities and resources have not been examined systematically in efforts to understand difference in older adults' health status across countries.
This project will assess the extent to which local contextual characteristics explain the worse health status of older Americans compared to their counterparts in England using data from the Health and Retirement Study (HRS) and English Longitudinal Study of Aging (ELSA). We will identify comparable local geographic areas in the HRS and ELSA and create a comparable contextual dataset to be linked to the ELSA at each geographic boundary. We will then assess the extent to which area-level contextual measures explain key health and mortality differences between the US and England, including comprehensive self-reported health measures, measures of physical performances (e.g., gait speed) and cognitive functioning, and biomarkers (e.g., HbA1c). We will also examine health gaps by age, education, and economic groups before and after the adjustments of local contextual characteristics.
PI: HwaJung Choi
CBSSM Co-Is: Michele Heisler & Kenneth Langa
Funded by Holden Research Fund Award
Funding Years: 2011
PI: Naomi Laventhal
Holly Witteman, Research Fellow at CBSSM, has been awarded a $25,000 Robert Derzon Post-Doctoral Grant from the Foundation for Informed Medical Decision Making for her project entitled "Development and Evaluation of Interactive Interfaces for Values Exploration and Clarification." Pending IRB approval, the project is slated to commence in April 2010. Witteman has been working since fall 2009 under the mentorship of Angela Fagerlin. CBSSM extends its congratulations!
Cancer screening is generally recommended for people over the age of 50. Screening tests, such as colonoscopies, mammograms and PSAs (prostatespecific antigen), can help detect cancer at an early stage andprevent deaths. These screening tests, however, do have risks so,along with their doctor, people need to make a decision about howoften to get screened and when or if one should stop gettingscreened.
Consider the question:
Now, imagine that you were screened for cancer about a year ago and no cancer was found. You and your doctor are talking about when you should come back for screening in the future. Your doctor explains that cancer screening guidelines recommend that you do come back for more screening tests but as you get older, screening for cancer is no longer a good option. Your doctor states that you should follow this recommendation as you age. Now, imagine that you were screened for cancer about a year ago and no cancer was found. You and your doctor are talking about when you should come back for screening in the future. Your doctor explains that cancer screening guidelines recommend that you do come back for more screening tests but as you get older, screening for cancer is no longer a good option. Your doctor states that you should follow this recommendation as you age.
How do your answers compare?
To learn more about this study, see:
Brian J. Zikmund-Fisher is an Associate Professor in the Department of Health Behavior and Health Education, University of Michigan School of Public Health, as well as a Research Associate Professor in the Division of General Internal Medicine, University of Michigan Medical School. He has been part of CBSSM and its precursors at U-M since 2002 and acts as CBSSM Associate Director.
Funded by Department of Health and Human Services - Agency for Health Care Research and Quality-Subcontracts
Funding Years: 2013 - 2015.
PI(s): Angela Fagerlin